ZBTB33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.201160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.660200E-01
Normal-vs-Stage2
1.030640E-01
Normal-vs-Stage3
1.320810E-01
Normal-vs-Stage4
8.706600E-01
Stage1-vs-Stage2
4.367400E-01
Stage1-vs-Stage3
2.196100E-02
Stage1-vs-Stage4
4.088800E-01
Stage2-vs-Stage3
9.199900E-03
Stage2-vs-Stage4
1.144640E-01
Stage3-vs-Stage4
1.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.086040E-01
Normal-vs-AfricanAmerican
6.728200E-01
Normal-vs-Asian
1.177640E-01
Caucasian-vs-AfricanAmerican
1.774230E-01
Caucasian-vs-Asian
5.109400E-01
AfricanAmerican-vs-Asian
1.929980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.609900E-02
Normal-vs-Female
1.730160E-01
Male-vs-Female
3.399800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.823800E-01
Normal-vs-Age(41-60Yrs)
4.397800E-01
Normal-vs-Age(61-80Yrs)
5.011800E-02
Normal-vs-Age(81-100Yrs)
1.437540E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.436400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.206000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.099900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.172300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.625900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.385600E-02
Normal-vs-Daily Drinker
1.849640E-02
Normal-vs-Weekly Drinker
1.553780E-02
Normal-vs-Occasional Drinker
7.601400E-01
Normal-vs-Social Drinker
3.557400E-01
Non Drinker-vs-Daily Drinker
6.304400E-01
Non Drinker-vs-Weekly Drinker
5.972200E-01
Non Drinker-vs-Occasional Drinker
2.383800E-02
Non Drinker-vs-Social Drinker
1.083580E-01
Daily Drinker-vs-Weekly Drinker
9.200000E-01
Daily Drinker-vs-Occasional Drinker
1.282060E-02
Daily Drinker-vs-Social Drinker
6.125800E-02
Weekly Drinker-vs-Occasional Drinker
1.242060E-02
Weekly Drinker-vs-Social Drinker
8.088000E-02
Occasional Drinker-vs-Social Drinker
3.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.243430E-01
Normal-vs-Grade 2
5.270400E-02
Normal-vs-Grade 3
2.387900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.493200E-01
Grade 1-vs-Grade 3
9.795200E-01
Grade 1-vs-Grade 4
1.243430E-01
Grade 2-vs-Grade 3
5.139000E-01
Grade 2-vs-Grade 4
5.270400E-02
Grade 3-vs-Grade 4
2.387900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.300020E-02
Normal-vs-NonDiabetic
1.211990E-01
Diabetic-vs-NonDiabetic
1.046010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.284100E-03
Normal-vs-NoPancreatitis
1.118420E-01
Pancreatitis-vs-NoPancreatitis
4.809900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.229180E-01
Normal-vs-N1
1.320440E-01
N0-vs-N1
7.169800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.387200E-01
Normal-vs-TP53-NonMutant
3.394800E-01
TP53-Mutant-vs-TP53-NonMutant
9.783400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
